Pommerening Matthew J, Goodman Michael D, Holcomb John B, Wade Charles E, Fox Erin E, Del Junco Deborah J, Brasel Karen J, Bulger Eileen M, Cohen Mitch J, Alarcon Louis H, Schreiber Martin A, Myers John G, Phelan Herb A, Muskat Peter, Rahbar Mohammad, Cotton Bryan A
Center for Translational Injury Research, University of Texas Health Science Center at Houston, United States; Division of Acute Care Surgery, Department of Surgery, University of Texas Health Science Center at Houston, United States.
Division of Trauma/Critical Care, Department of Surgery, College of Medicine, University of Cincinnati, United States.
Injury. 2015 May;46(5):807-13. doi: 10.1016/j.injury.2014.12.026. Epub 2015 Feb 4.
Early recognition and treatment of trauma patients requiring massive transfusion (MT) has been shown to reduce mortality. While many risk factors predicting MT have been demonstrated, there is no universally accepted method or algorithm to identify these patients. We hypothesised that even among experienced trauma surgeons, the clinical gestalt of identifying patients who will require MT is unreliable.
Transfusion and mortality outcomes after trauma were observed at 10 U.S. Level-1 trauma centres in patients who survived ≥ 30 min after admission and received ≥ 1 unit of RBC within 6h of arrival. Subjects who received ≥ 10 units within 24h of admission were classified as MT patients. Trauma surgeons were asked the clinical gestalt question "Is the patient likely to be massively transfused?" 10 min after the patients arrival. The performance of clinical gestalt to predict MT was assessed using chi-square tests and ROC analysis to compare gestalt to previously described scoring systems.
Of the 1245 patients enrolled, 966 met inclusion criteria and 221 (23%) patients received MT. 415 (43%) were predicted to have a MT and 551(57%) were predicted to not have MT. Patients predicted to have MT were younger, more often sustained penetrating trauma, had higher ISS scores, higher heart rates, and lower systolic blood pressures (all p<0.05). Gestalt sensitivity was 65.6% and specificity was 63.8%. PPV and NPV were 34.9% and 86.2% respectively.
Data from this large multicenter trial demonstrates that predicting the need for MT continues to be a challenge. Because of the increased mortality associated with delayed therapy, a more reliable algorithm is needed to identify and treat these severely injured patients earlier.
已证实,对需要大量输血(MT)的创伤患者进行早期识别和治疗可降低死亡率。虽然已证实许多预测MT的风险因素,但尚无普遍接受的方法或算法来识别这些患者。我们假设,即使在经验丰富的创伤外科医生中,识别需要MT的患者的临床直觉也不可靠。
在美国10个一级创伤中心观察创伤后输血和死亡率结果,这些患者入院后存活≥30分钟,且在到达后6小时内接受≥1单位红细胞。入院后24小时内接受≥10单位输血的患者被归类为MT患者。在患者到达后10分钟,询问创伤外科医生临床直觉问题“该患者是否可能需要大量输血?”。使用卡方检验和ROC分析评估临床直觉预测MT的性能,以将直觉与先前描述的评分系统进行比较。
在纳入的1245例患者中,966例符合纳入标准,221例(23%)患者接受了MT。415例(43%)被预测需要MT,551例(57%)被预测不需要MT。被预测需要MT的患者更年轻,更常遭受穿透性创伤,损伤严重度评分(ISS)更高,心率更高,收缩压更低(所有p<0.05)。直觉的敏感性为65.6%,特异性为63.8%。阳性预测值和阴性预测值分别为34.9%和86.2%。
这项大型多中心试验的数据表明,预测MT需求仍然是一项挑战。由于延迟治疗会增加死亡率,因此需要一种更可靠的算法来更早地识别和治疗这些重伤患者。